AI assistant
Sending…
AMGEN INC — Director's Dealing 2017
Dec 13, 2017
29819_dirs_2017-12-12_55b06e70-7a76-44c0-a47c-f3b27fb42bf4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2017-12-11
Reporting Person: Austin Wanda M (Director)
More from AMGEN INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7